Sravan Kumar Emany Beam Therapeutics Inc. (BEAM) insider trading activity

Sravan Kumar Emany is Chief Financial Officer of Beam Therapeutics Inc.. Currently has a direct ownership of 80,000 shares of BEAM, which is worth approximately $2.11 Million. The most recent transaction as insider was on Dec 31, 2024, when has been sold 80,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 80K

n/a 3M change

n/a 12M change

Total Value Held $2.11 Million

Sravan Kumar Emany Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Dec 31 2024	BUY Grant, award, or other acquisition	-	80,000 Added 50.0%	80,000 Common Stock

Also insider at

IRWD

IRONWOOD PHARMACEUTICALS INC Healthcare

SVP, COO and CFO

ASRT

Assertio Holdings, Inc. Healthcare

Director

SKE